Skip to main content

previous disabled Page of 89
and
  1. Article

    Open Access

    Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has significantly improved the survival of patients with GISTs. We aimed to evalu...

    Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, Chin-Fu Hsiao, Chung-Hsin Tsai in BMC Cancer (2024)

  2. Article

    Open Access

    Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects

    Malaria-elimination interventions aim to extinguish hotspots and prevent transmission to nearby areas. Here, we re-analyzed a cluster-randomized trial of reactive, focal interventions (chemoprevention using ar...

    Jade Benjamin-Chung, Haodong Li, Anna Nguyen, Gabriella Barratt Heitmann in Nature Medicine (2024)

  3. Article

    Open Access

    A holistic lifestyle mobile health intervention for the prevention of type 2 diabetes and common mental disorders in Asian women with a history of gestational diabetes: a randomised control trial with 3-year follow-up protocol

    Women with a history of gestational diabetes mellitus (GDM) are 12-fold more likely to develop type 2 diabetes (T2D) 4–6 years after delivery than women without GDM. Similarly, GDM is associated with the devel...

    Alicia Salamanca-Sanabria, Seaw Jia Liew, Jacqueline Mair, Maria De Iorio in Trials (2024)

  4. Article

    Open Access

    The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): study protocol for a multi-center, prospective, randomized trial

    The role of cytoreductive nephrectomy (CN) in the treatment of metastatic renal cell carcinoma (mRCC) remains unclear in the immuno-oncology (IO) era. The results of two randomized trials, CARMENA and SURTIME,...

    Jee Soo Park, Jongchan Kim, **hyung Jeon, Jongsoo Lee, Won Sik Jang in Trials (2024)

  5. Article

    Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

    Nabil F. Saba, Conor E. Steuer, Asari Ekpenyong, Ashley McCook-Veal in Nature Medicine (2024)

  6. No Access

    Article

    Intranasal delivery of siRNA targeting NR2B attenuates cancer-associated neuropathic pain

    This study aimed to reduce cancer-associated pain by blocking pain signals through the intranasal administration of siRNA targeting the NMDA subunit NR2B (siNR2B).

    Kunho Chung, Hyoung-Gon Ko, Yujong Yi in Journal of Pharmaceutical Investigation (2024)

  7. No Access

    Article

    Effects of hypertension and use of antihypertensive drugs in pregnancy on the risks of childhood cancers in Taiwan

    Childhood cancers are associated with high mortality and morbidity, and some maternal prescription drug use during pregnancy has been implicated in cancer risk. There are few studies on the effects of hyperten...

    Helen T. Orimoloye, Ya-Hui Hu, Noah Federman, Beate Ritz in Cancer Causes & Control (2024)

  8. No Access

    Article

    Blocking Fas signaling in adipose tissue ameliorates obesity-associated inflammation, insulin resistance, and hepatosteatosis

    Adipose tissue inflammation is a crucial early stage of obesity-related metabolic dysfunction and insulin resistance. Adipocytes, and infiltrating immune cells in the adipose tissue, play significant roles in ...

    Jagadish Beloor, Irfan Ullah, Jongkil Kim in Journal of Pharmaceutical Investigation (2024)

  9. No Access

    Article

    Micro-current stimulation could inhibit IL-1β-induced inflammatory responses in chondrocytes and protect knee bone cartilage from osteoarthritis

    This study aimed to evaluate the inhibitory effects of micro-current stimulation (MCS) on inflammatory responses in chondrocytes and degradation of extracellular matrix (ECM) in osteoarthritis (OA). To determi...

    Minjoo Lee, Hana Lee, Halim Chung, **-Ho Lee, Doyong Kim in Biomedical Engineering Letters (2024)

  10. Article

    Open Access

    Epithelial−mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer

    We investigated the role of tumor cell-intrinsic PD-L1 signaling in the epithelial−mesenchymal transition (EMT) in non-small-cell lung cancer (NSCLC) and the role of EMT as a predictive biomarker for immune ch...

    Hyein Jeong, Jaemoon Koh, Sehui Kim, Seung Geun Song in British Journal of Cancer (2024)

  11. Article

    Open Access

    Editorial expression of concern: Protective effect of Curcuma longa L. extract on CCl4-induced acute hepatic stress

    Geum-Hwa Lee, Hwa-Young Lee, Min-Kyung Choi, Han-Wool Chung in BMC Research Notes (2024)

  12. No Access

    Article

    Chimeric antigen receptor T cell therapy for autoimmune disease

    Infusion of T cells engineered to express chimeric antigen receptors (CARs) that target B cells has proven to be a successful treatment for B cell malignancies. This success inspired the development of CAR T c...

    James B. Chung, Jennifer N. Brudno, Dominic Borie in Nature Reviews Immunology (2024)

  13. Article

    Open Access

    Chronic ultraviolet irradiation induces memory deficits via dysregulation of the dopamine pathway

    The effects of ultraviolet (UV) radiation on brain function have previously been investigated; however, the specific neurotransmitter-mediated mechanisms responsible for UV radiation-induced neurobehavioral ch...

    Kyeong-No Yoon, Sun Yong Kim, Jungeun Ji, Yidan Cui in Experimental & Molecular Medicine (2024)

  14. No Access

    Article

    The BTLA–HVEM axis restricts CAR T cell efficacy in cancer

    The efficacy of T cell-based immunotherapies is limited by immunosuppressive pressures in the tumor microenvironment. Here we show a predominant role for the interaction between BTLA on effector T cells and HV...

    Puneeth Guruprasad, Alberto Carturan, Yunlin Zhang, Jong Hyun Cho in Nature Immunology (2024)

  15. Article

    Open Access

    Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma

    Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor survival rate, largely due to the lack of early diagnosis. Although myeloid cells are crucial in the tumour microenvironment, whe...

    Hyung Keun Lee, So Young Kim, Soo-Hyun Chung, Bongkun Choi in British Journal of Cancer (2024)

  16. No Access

    Article

    The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study

    Breast cancer in young patients is known to exhibit more aggressive biological behavior and is associated with a less favorable prognosis than the same disease in older patients, owing in part to an increased ...

    Allison L. Hunt, Imran Khan, Alex M. L. Wu in Clinical & Experimental Metastasis (2024)

  17. Article

    Open Access

    Genetic mutation patterns among glioblastoma patients in the Taiwanese population – insights from a single institution retrospective study

    This study utilized Next-Generation Sequencing (NGS) to explore genetic determinants of survival duration in Glioblastoma Multiforme (GBM) patients. We categorized 30 primary GBM patients into two groups based...

    Yu-Fen Huang, Ming-Tsang Chiao, Tzu-Hung Hsiao, Yong-**ang Zhan in Cancer Gene Therapy (2024)

  18. Article

    Open Access

    Comparison of infectious complications with BCMA-directed therapies in multiple myeloma

    B-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge. In this retrospective, single-center analysis we evaluated infectio...

    Karthik Nath, Tala Shekarkhand, David Nemirovsky, Andriy Derkach in Blood Cancer Journal (2024)

  19. Article

    Open Access

    Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma

    Despite being the mainstay of management for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), there is limited data regarding the impact of tocilizumab (TCZ) ...

    Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura in Blood Cancer Journal (2024)

  20. Article

    Open Access

    Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial

    Trastuzumab deruxtecan (T-DXd) showed statistically significant clinical improvement in patients with human epidermal growth factor receptor 2-positive (HER2+) gastric cancer in the DESTINY-Gastric01 trial. Explo...

    Kohei Shitara, Yung-Jue Bang, Satoru Iwasa, Naotoshi Sugimoto in Nature Medicine (2024)

previous disabled Page of 89